Weiss Ratings Reiterates Sell (E+) Rating for 111 (NASDAQ:YI)

Weiss Ratings reissued their sell (e+) rating on shares of 111 (NASDAQ:YI) in a research note issued to investors on Friday morning,Weiss Ratings reports.

111 Trading Down 0.6 %

111 stock opened at $8.66 on Friday. The stock has a 50 day moving average of $6.57 and a two-hundred day moving average of $7.27. 111 has a twelve month low of $4.15 and a twelve month high of $15.80. The stock has a market capitalization of $74.06 million, a price-to-earnings ratio of -2.17 and a beta of 0.46.

Institutional Investors Weigh In On 111

A number of hedge funds have recently added to or reduced their stakes in the company. FIL Ltd acquired a new position in shares of 111 during the 4th quarter worth $450,000. JPMorgan Chase & Co. boosted its position in shares of 111 by 43,619.9% in the 4th quarter. JPMorgan Chase & Co. now owns 306,039 shares of the company’s stock worth $191,000 after buying an additional 305,339 shares in the last quarter. Finally, Napean Trading & Investment Co Singapore PTE Ltd acquired a new stake in shares of 111 in the fourth quarter valued at approximately $245,000. Institutional investors and hedge funds own 21.32% of the company’s stock.

About 111

111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.